adamantane has been researched along with 14,15-epoxy-5,8,11-eicosatrienoic acid in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Campbell, WB; Falck, JR; Gauthier, KM; Gross, GJ; Hammock, BD; Moore, J; Nithipatikom, K | 1 |
Alkayed, NJ; Cao, Z; Iliff, J; Liu, L; Merkel, MJ; Motoki, A; Packwood, WH; Van Winkle, DM | 1 |
Diani-Moore, S; Gross, SS; Ma, Y; Rifkind, AB | 1 |
Cao, X; Gao, T; Li, X; Lin, L; Liu, S; Luo, P; Qin, X; Sun, A; Wang, X; Wu, Q; Zhu, X | 1 |
Fang, Y; Huang, X; Liu, Y; Ning, Q; Wan, Y; Wang, W; Xie, M; Xu, S; Yao, E; Zhang, G | 1 |
Chang, WK; Gan, YL; Hsu, PC; Hu, YY; Huang, YJ; Hung, CC; Kao, LS; Kuo, YM; Lee, YH; Lin, CH; Shie, FS; Tsou, MY | 1 |
Guan, Y; Jia, YL; Jiang, JX; Liu, Q; Shen, HJ; Shen, J; Xie, QM; Zhang, LH; Zhu, YL | 1 |
7 other study(ies) available for adamantane and 14,15-epoxy-5,8,11-eicosatrienoic acid
Article | Year |
---|---|
Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Blood Pressure; Cardiovascular Agents; Coronary Circulation; Diazoxide; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoxide Hydrolases; Female; Heart Rate; Lauric Acids; Male; Mitochondria, Heart; Myocardial Infarction; Myocardium; Potassium Channels | 2008 |
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Female; Gene Deletion; Heart Ventricles; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Time Factors; Urea | 2008 |
Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolas
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Chick Embryo; Enzyme Inhibitors; Epoxide Hydrolases; Gene Expression Regulation, Enzymologic; Heart; Hydroxyeicosatetraenoic Acids; Lauric Acids; Liver; Polychlorinated Dibenzodioxins; RNA, Messenger | 2014 |
Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Behavior, Animal; Cell Survival; Cells, Cultured; Dopaminergic Neurons; Epoxide Hydrolases; Lauric Acids; Male; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Paraquat; Parkinsonian Disorders; Rotarod Performance Test; Solubility; Substantia Nigra; Tyrosine 3-Monooxygenase; Up-Regulation | 2015 |
Epoxyeicosanoid Signaling Provides Multi-target Protective Effects on Neurovascular Unit in Rats After Focal Ischemia.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Apoptosis; Epoxide Hydrolases; Infarction, Middle Cerebral Artery; Lauric Acids; Male; Neovascularization, Physiologic; Neuroglia; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Signal Transduction | 2016 |
Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Astrocytes; Cell Survival; Cells, Cultured; Enzyme Inhibitors; Epoxide Hydrolases; Excitatory Amino Acid Transporter 2; Glutamic Acid; Hippocampus; Homeostasis; Kainic Acid; Lauric Acids; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 8; Models, Biological; N-Methylaspartate; Neuroglia; Neuronal Plasticity; Neurons; Neurotoxins; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Solubility | 2019 |
Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Airway Remodeling; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Disease Models, Animal; Epoxide Hydrolases; Female; Humans; Lauric Acids; Lung; MAP Kinase Signaling System; Mice; Ovalbumin; Signal Transduction; STAT3 Transcription Factor | 2020 |